18.97Average Price Target
The highest estimate is 28.83.
From 5 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow KUR.STU. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Show more...
FAQ
What is Kura Oncology stock price today?▼
The current price of KUR.STU is €11.55 EUR — it has increased by +1.32% in the past 24 hours. Watch Kura Oncology stock price performance more closely on the chart.
What is Kura Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Kura Oncology stocks are traded under the ticker KUR.STU.
Is Kura Oncology stock price growing?▼
KUR.STU stock has risen by +4.05% compared to the previous week, the month change is a +41.54% rise, over the last year Kura Oncology has showed a +68.37% increase.
What is Kura Oncology market cap?▼
Today Kura Oncology has the market capitalization of 1.03B
When is the next Kura Oncology earnings date?▼
Kura Oncology is going to release the next earnings report on October 29, 2026.
What were Kura Oncology earnings last quarter?▼
KUR.STU earnings for the last quarter are -0.67 EUR per share, whereas the estimation was -0.76 EUR resulting in a +12.23% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Kura Oncology revenue for the last year?▼
Kura Oncology revenue for the last year amounts to 58.46M EUR.
What is Kura Oncology net income for the last year?▼
KUR.STU net income for the last year is -241.36M EUR.
How many employees does Kura Oncology have?▼
As of September 08, 2026, the company has 260 employees.
In which sector is Kura Oncology located?▼
Kura Oncology operates in the Health & Wellness sector.
When did Kura Oncology complete a stock split?▼
Kura Oncology has not had any recent stock splits.
Where is Kura Oncology headquartered?▼
Kura Oncology is headquartered in SAN DIEGO, United States.